Table 1.
Baseline characteristics of all eyes included in the study.
| Criteria | All eyes | Visible CNV group | Putative CNV group | P-value |
|---|---|---|---|---|
| Patients (n) | 16 | 6 | 10 | — |
| Age (mean ± SD) | 51.1 ± 8.0 | 51.9 ± 8.1 | 50.6 ± 7.9 | 0.762 |
| Gender (male/Female) | 9/6 | 3/3∗ | 6/4∗ | 0.696 |
| Mean interval of follow-up (months) (mean ± SD) | 3.90 ± 3.37 | 4.29 ± 3.42 | 3.67 ± 3.32 | 0.743 |
| Affected eye (right/Left) | 7/9 | 3/3 | 4/6 | 0.696 |
| The number of injections (mean ± SD) | 2.69 ± 1.72 | 2.67 ± 2.13 | 2.70 ± 1.42 | 0.973 |
| Mean interval between injections in months (mean ± SD) | 1.34 ± 0.87 | 1.42 ± 0.99 | 1.29 ± 0.78 | 0.716 |
| Type of fluid accumulation (Subretinal/PED) | 16/16 | 6/6 | 10/10 | — |
CNV, choroidal neovascularization; PED, pigment epithelial detachment. The data were represented as mean ± SD; ∗ one patient with both eyes affected. The statistics was analyzed by the chi-square test or independent t-test when appropriated.